Deviations from the planned dose during 48 hours of stepping source prostate brachytherapy caused by anatomical variations.

BACKGROUND AND PURPOSE To determine the uncertainties in planned dose associated with catheter and organ movement during 48 hours of stepping source prostate brachytherapy. MATERIAL AND METHODS Pulsed-dose rate (PDR) prostate brachytherapy as a boost is given in 24 pulses every 2 hours, making the total treatment last 48 hours. The entire treatment is based on one plan, created on the planning CT (CT1). Two follow-up CTs (CT2 and CT3) were acquired; halfway through the treatment and at the end of treatment. On these repeat scans the catheters were reconstructed and PTV and OARs were delineated. The original treatment plan was calculated on the repeat CTs. Target coverage V(100%), D(90), dose to 2cm(3) (D2cm(3)) of the rectum and bladder and dose to 0.1cm(3) of the urethra were recorded from the recalculated DVHs. RESULTS On the two repeat CTs the V100% decreased -1.5% and -2.3% as compared to the planning CT. For the rectum D2cm(3), the average increase was 14.8% (CT1-CT2) and 17.3% (CT1-CT3). Increase in bladder D2cm(3) was on average 23.1% (CT1-CT2) and 24.8% (CT1-CT3). For the urethra D0.1cm(3) an average decrease of -2% (CT1-CT2) and -3.2% (CT2-CT3) was observed. CONCLUSIONS Changes in target coverage during treatment were small and considered clinically irrelevant. However, an overall increase in dose to the OARs was found as compared to the planned dose, which should be taken into account during treatment planning.

[1]  J. Pouliot,et al.  Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy. , 2011, International journal of radiation oncology, biology, physics.

[2]  Ivan Yeung,et al.  Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. , 2004, International journal of radiation oncology, biology, physics.

[3]  Gerry Lowe,et al.  Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  R. Steenbakkers,et al.  Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. , 2003, International journal of radiation oncology, biology, physics.

[5]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[6]  Filip Claus,et al.  Interobserver Delineation Variation Using CT versus Combined CT + MRI in Intensity–Modulated Radiotherapy for Prostate Cancer , 2005, Strahlentherapie und Onkologie.

[7]  S J Damore,et al.  Needle displacement during HDR brachytherapy in the treatment of prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[8]  Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[9]  Andrew See,et al.  High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial. , 2012, International journal of radiation oncology, biology, physics.

[10]  C. Pelizzari,et al.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[11]  Louis Potters,et al.  Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. , 2007, International journal of radiation oncology, biology, physics.

[12]  T. Pisansky,et al.  Dosimetric effect of interfractional needle displacement in prostate high-dose-rate brachytherapy. , 2009, Brachytherapy.

[13]  J. Dimopoulos,et al.  Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. , 2012, International journal of radiation oncology, biology, physics.

[14]  C. Fiorino,et al.  Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  R. Fietkau,et al.  Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  J. Pouliot,et al.  Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. , 2004, International journal of radiation oncology, biology, physics.

[17]  Y. Yoshioka,et al.  Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. , 2011, International journal of radiation oncology, biology, physics.

[18]  Shafak Aluwini,et al.  HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  H. Patrocinio,et al.  Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy. , 2010, Brachytherapy.

[20]  R. Stock,et al.  Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. , 2001, International journal of radiation oncology, biology, physics.

[21]  C. Kirisits,et al.  PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  G. Gustafson,et al.  Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. , 2007, International journal of radiation oncology, biology, physics.

[23]  E. D. Geijsen,et al.  Development of late toxicity and International Prostate Symptom Score resolution after external-beam radiotherapy combined with pulsed dose rate brachytherapy for prostate cancer. , 2011, International journal of radiation oncology, biology, physics.

[24]  M van Herk,et al.  Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[25]  P. Hoskin,et al.  High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.

[27]  R. Sloboda,et al.  Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging. , 2009, Brachytherapy.

[28]  C. Koning,et al.  Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[30]  P. Hoskin,et al.  Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  J. Pouliot,et al.  American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. , 2012, Brachytherapy.

[32]  Bradley R Pieters,et al.  Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.